Consent Agreement to Allow Continued Operation of Pharmaceutical Manufacturing and Related Hazardous Waste Treatment Activity on Aerojet-General Corporation's P

Summary

SCH Number
2005128004
Public Agency
Department of Toxic Substances Control
Document Title
Consent Agreement to Allow Continued Operation of Pharmaceutical Manufacturing and Related Hazardous Waste Treatment Activity on Aerojet-General Corporation's P
Document Type
NOE - Notice of Exemption
Received
Posted
12/1/2005
Document Description
The project involves DTSC's issuance of a Consent Agreement to allow AMPAC to continue AFC's pharmaceutical manufacturing operation, which includes treatment of hazardous waste, pending AMPAC's application for a hazardous waste facility permit or other forms of authorization. DTSC has determined that treatment of liquid hazardous waste occurs during part of the pharmaceutical production process and a Consent Agreement is necessary to ensure the continued safe operation of the facility pending AMPAC's application for a hazardous waste facility permit or other forms of authorization. The Consent Agreement requires AMPAC to comply with the State hazardous waste management requirements.

Contact Information

Name
Kim Wilhelm
Agency Name
Department of Toxic Substances Control
Contact Types
Lead/Public Agency

Location

Counties
Sacramento
Regions
Unincorporated

Notice of Exemption

Exempt Status
Other
Type, Section or Code
Section 15061(b)(3)
Reasons for Exemption
This short-term Consent Agreement is issued by DTSC to allow continued operation. It requires AMPAC to comply with all applicable state laws and regulations governing hazardous waste management. In addition, project specific parameters that limit the potential impact of the project include the following: 1. AMPAC will review each proposed new manufacturing process to ensure its safety. 2. Air permits are obtained from the Sacramento Metropolitan Air Quality Management District for each process prior to its commencement and are based on the engineer's proposed design and anticipated emissions. 3. Aeroject is entirely fenced and the gates are manned with 24 hour security guard service. Aeroject maintains a fire service and haz mat group that will continue to provide services to AMPAC's pharmaceutical manufacturing processes. 4. All manufacturing programs are reviewed for hazards during their design phase by a team consisting of engineers, operators, chemists, and environmental health and safety personnel.

Disclaimer: The document was originally posted before CEQAnet had the capability to host attachments for the public. To obtain the original attachments for this document, please contact the lead agency at the contact information listed above. You may also contact the OPR via email at state.clearinghouse@opr.ca.gov or via phone at (916) 445-0613.

Download CSV New Search Print